ZA948590B - Vaccine design and production - Google Patents

Vaccine design and production

Info

Publication number
ZA948590B
ZA948590B ZA948590A ZA948590A ZA948590B ZA 948590 B ZA948590 B ZA 948590B ZA 948590 A ZA948590 A ZA 948590A ZA 948590 A ZA948590 A ZA 948590A ZA 948590 B ZA948590 B ZA 948590B
Authority
ZA
South Africa
Prior art keywords
production
vaccine design
vaccine
design
Prior art date
Application number
ZA948590A
Other languages
English (en)
Inventor
Curtis Coats Scheifinger
David Lee Smiley
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA948590B publication Critical patent/ZA948590B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA948590A 1993-11-05 1994-11-01 Vaccine design and production ZA948590B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14776593A 1993-11-05 1993-11-05

Publications (1)

Publication Number Publication Date
ZA948590B true ZA948590B (en) 1996-05-02

Family

ID=22522813

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA948590A ZA948590B (en) 1993-11-05 1994-11-01 Vaccine design and production

Country Status (21)

Country Link
US (1) US5679349A (ru)
EP (1) EP0726774A4 (ru)
JP (1) JPH09505039A (ru)
KR (1) KR960705582A (ru)
CN (2) CN1087953C (ru)
AU (1) AU1050595A (ru)
BR (1) BR9407988A (ru)
CA (1) CA2175708A1 (ru)
CZ (1) CZ128896A3 (ru)
FI (1) FI961869A (ru)
HU (1) HUT75556A (ru)
NO (1) NO961808L (ru)
NZ (1) NZ276290A (ru)
PL (1) PL314303A1 (ru)
RO (1) RO116045B1 (ru)
RU (1) RU2143920C1 (ru)
SG (1) SG49830A1 (ru)
TW (1) TW448185B (ru)
UA (1) UA42741C2 (ru)
WO (1) WO1995012410A1 (ru)
ZA (1) ZA948590B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2333750A1 (en) * 1998-06-23 1999-12-29 Dale T. Umetsu Adjuvant therapy
JP2003171291A (ja) * 1999-10-29 2003-06-17 Takeda Schering-Plough Animal Health Kk 乳房炎用粘膜予防剤
US6984381B2 (en) 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
GB0219524D0 (en) 2002-08-21 2002-10-02 Queen Mary & Westfield College Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
GB0802931D0 (en) 2008-02-18 2008-03-26 Queen Mary & Westfield College Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal anitbody variable regions
CN102716475A (zh) * 2012-06-29 2012-10-10 黑龙江省科学院微生物研究所 一种奶牛乳房炎疫苗的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0672123A1 (en) * 1992-01-08 1995-09-20 The Rockefeller University Multifunctional surface protein of streptococci

Also Published As

Publication number Publication date
NO961808D0 (no) 1996-05-03
FI961869A0 (fi) 1996-05-02
CN1380422A (zh) 2002-11-20
HU9601191D0 (en) 1996-06-28
AU1050595A (en) 1995-05-23
PL314303A1 (en) 1996-09-02
EP0726774A1 (en) 1996-08-21
HUT75556A (en) 1997-05-28
BR9407988A (pt) 1996-12-03
UA42741C2 (ru) 2001-11-15
TW448185B (en) 2001-08-01
CA2175708A1 (en) 1995-05-11
US5679349A (en) 1997-10-21
NZ276290A (en) 1997-11-24
FI961869A (fi) 1996-05-02
WO1995012410A1 (en) 1995-05-11
EP0726774A4 (en) 2001-06-27
CN1141000A (zh) 1997-01-22
SG49830A1 (en) 1998-06-15
CZ128896A3 (en) 1996-10-16
RO116045B1 (ro) 2000-10-30
CN1087953C (zh) 2002-07-24
NO961808L (no) 1996-06-27
RU2143920C1 (ru) 2000-01-10
KR960705582A (ko) 1996-11-08
JPH09505039A (ja) 1997-05-20

Similar Documents

Publication Publication Date Title
IL108385A0 (en) Ornament
ZA9215B (en) Oxides and the production thereof
ZA947828B (en) Vaccines
GB9401026D0 (en) Solutions and their preparation
GB2276806B (en) Ornament
GB9325496D0 (en) Vaccines
SG49853A1 (en) Novel macrolides and the use thereof
GB2281830B (en) I/q-modulator and i/q-demodulator
EP0549801A4 (en) Diamond-covered member and production thereof
HU9601191D0 (en) Vaccine design and production
GB9321673D0 (en) Pillows
GB9322702D0 (en) Vaccines
ZA948729B (en) Vaccines
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
EP0505941A3 (en) Peptifluorin and neopeptifluorin
AU1122692A (en) Stockfeed and the production thereof
GB9212816D0 (en) Vaccines and their uses
GB9323754D0 (en) Vaccine
GB9323820D0 (en) Vaccine
GB9306398D0 (en) Vaccines
GB9304056D0 (en) Vaccines
GB9312641D0 (en) Vaccines
GB9314520D0 (en) Vaccines
GB9315098D0 (en) Vaccines
GB9304269D0 (en) Aerogel-containing galzing unit and manufacture thereof